| 665818 |
FRONTIERS IN ONCOLOGY |
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling |
2021-03-16 |
10.3389/fonc.2021.633543 |
Pantaleo Maria A., Mandruzzato Marcella, Indio Valentina, Urbini Milena, Nannini Margherita, Gatto Lidia, Schipani Angela, Fiorentino Michelangelo, Franceschini Tania, Ambrosini Valentina, Di Scioscio Valerio, Saponara Maristella, Ianni Manuela, Concetti Sergio, Altimari Annalisa, Ardizzoni Andrea, Astolfi Annalisa |
| 665817 |
FRONTIERS IN ONCOLOGY |
Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents |
2021-03-16 |
10.3389/fonc.2021.608816 |
Biegel Jason M., Dhamdhere Mayura, Gao Shuang, Gowda Chethana P., Kawasawa Yuka Imamura, Spiegelman Vladimir S. |
| 665816 |
FRONTIERS IN ONCOLOGY |
Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications |
2021-03-16 |
10.3389/fonc.2021.622752 |
Yang Miner, Chen Gaowen, Gao Kunjie, Wang Yifeng |
| 665815 |
FRONTIERS IN ONCOLOGY |
Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment |
2021-03-16 |
10.3389/fonc.2021.623760 |
Franco Marina Santiago, Gomes Eliza Rocha, Roque Marjorie Coimbra, Oliveira Mônica Cristina |
| 665814 |
FRONTIERS IN ONCOLOGY |
High Expression of Interleukin-3 Receptor Alpha Chain (CD123) Predicts Favorable Outcome in Pediatric B-Cell Acute Lymphoblastic Leukemia Lacking Prognosis-Defining Genomic Aberrations |
2021-03-16 |
10.3389/fonc.2021.614420 |
Li Zhiheng, Chu Xinran, Gao Li, Ling Jing, Xiao Peifang, Lu Jun, Wang Yi, He Hailong, Li Jianqin, Hu Yixin, Li Jie, Pan Jian, Xiao Sheng, Hu Shaoyan |
| 665813 |
FRONTIERS IN ONCOLOGY |
Prediction of Microvascular Invasion in Hepatocellular Carcinoma With a Multi-Disciplinary Team-Like Radiomics Fusion Model on Dynamic Contrast-Enhanced Computed Tomography |
2021-03-16 |
10.3389/fonc.2021.660629 |
Zhang Wanli, Yang Ruimeng, Liang Fangrong, Liu Guoshun, Chen Amei, Wu Hongzhen, Lai Shengsheng, Ding Wenshuang, Wei Xinhua, Zhen Xin, Jiang Xinqing |
| 665812 |
FRONTIERS IN ONCOLOGY |
Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres® Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis |
2021-03-16 |
10.3389/fonc.2021.576232 |
Liang Bin, Makamure Joyman, Shu Shenglei, Zhang Lijie, Sun Tao, Zheng Chuansheng |
| 665811 |
FRONTIERS IN ONCOLOGY |
ROS-Mediated Necrosis by Glycolipid Biosurfactants on Lung, Breast, and Skin Melanoma Cells |
2021-03-16 |
10.3389/fonc.2021.622470 |
Haque Farazul, Khan Mohd Sajjad Ahmad, AlQurashi Naif |
| 665810 |
FRONTIERS IN ONCOLOGY |
Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines |
2021-03-16 |
10.3389/fonc.2021.628914 |
Yuan Bo, Xu Kang, Shimada Ryota, Li JingZhe, Hayashi Hideki, Okazaki Mari, Takagi Norio |
| 665809 |
FRONTIERS IN ONCOLOGY |
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters |
2021-03-16 |
10.3389/fonc.2021.626104 |
Sharova Evgeniya, Maruzzo Marco, Del Bianco Paola, Cavallari Ilaria, Pierantoni Francesco, Basso Umberto, Ciminale Vincenzo, Zagonel Vittorina |
